Clinical Uses and Adverse Effects Flashcards
- Clinical uses
Effective agent against Pseudomembranous colitis
Drug of choice for resistant infections such as MRSA and MRSE - Adverse effect
Red Man Syndrome
vancomycin
Its only use is for topical application to skin, wounds, or mucous membranes.
bacitracin
It is used as a second-line drug in the
treatment of tuberculosis.
cycloserine
- Clinical Uses
Because of their toxicity and poor distribution to tissues, the polymyxins were used primarily topically and rarely for systemic infections.
Clinically useful member is Polymyxin E
(colistin) and Polymyxin B.
polymyxins
- Clinical uses
Used most widely against gram-negative
enteric bacteria or when there is suspicion of sepsis. Poor bioavailability, hence, IM
administration.
The group includes streptomycin, neomycin, kanamycin, amikacin, gentamicin, tobramycin, sisomicin, netilmicin, arbekacin, and dibekacin. Spectinomycin is an aminocyclitol antibiotic (related to aminoglycosides) - Adverse effects
All are potentially ototoxic, vestibulotoxic and nephrotoxic, although to different degrees.
aminoglycosides
- Clinical uses
Widest or broadest spectrum among the
antibiotics and susceptible against gram-
positive and gram-negative bacteria & are
drugs of choice in infections caused by
rickettsiae, Anaplasma, Bartonella,
chlamydiae, and Mycoplasma pneumoniae. Include tetracycline, doxycycline,
minocycline, demeclocycline. - Adverse effects
Avid chelators of metals, contraindicated in children, Fanconi-like syndrome, renal
failure, ototoxicity, and phototoxicity.
tetracyclines
- Clinical Uses
- Tigecycline, the only agent, is the 9-tert-
butyl-glycylamido derivative of minocycline. - Tigecycline is active against a broad
spectrum of gram-positive and gram-
negative pathogens. - Compared with the tetracyclines, it is more active against MRSA and S epidermidis, drug-susceptible and drug-resistant S pneumoniae, and enterococci.
glycylcyclines
- Clinical Uses
Substitutes for penicillins in persons with
hypersensitivity.
Clinically useful agents include erythromycin, azalides (clarithromycin and azithromycin).
The ketolide, Telithromycin, is semisynthetic
derivative of erythromycin. - Adverse effects
Drug fever, mild GI upsets. Cholestatic
hepatitis in erythromycin estolate. Cardiac
arrhythmias in azithromycin.
Erythromycin, Clarithromycin, Azithromycin
macrolides
- Clinical Uses
Clindamycin and lincomycin are clinically
useful agents.
Active against Bacteroides species and other anaerobes infection.
Effective for skin and soft tissue infections. - Adverse effects
Prominent as a cause of antibiotic-
associated colitis caused by C. difficile.
lincosamides
- Clinical Uses
Its spectrum is similar to those of the
tetracyclines.
Extensively useful for treatment of typhoid fever.
It is bacteriostatic against Salmonella typhi, but has bactericidal activity against the three important encapsulated organisms that cause meningitis: Haemophilus influenzae, Streptococcus pneumoniae, and Neisseria meningitidis. - Adverse effects
Gray baby syndrome, bone marrow
suppression (aplastic anemia)
chloramphenicol
- Clinical Uses
Linezolid and tedizolid are useful agents.
Most frequently used to treat pneumonia, bacteremia, and skin and soft tissue infections caused by vancomycin-resistant staphylococci and enterococci. - Adverse effects
Reversible thrombocytopenia
oxazolidinones
- Clinical Uses
Quinupristin–dalfopristin (Synercid) is an
injectable streptogramin antibiotic consisting of a 30:70 mixture of two semisynthetic derivatives of pristinamycin (a group B streptogramin) and dalfopristin (a group A streptogramin).
The two components act synergistically to inhibit a wide spectrum of gram-positive
bacteria, including methicillin-resistant
staphylococci, VRE, and penicillin resistant pneumococci.
streptogramins
- Clinical Uses
Effective in urinary tract infections.
Treatment of sexually transmitted diseases (N. gonorrhoeae and C. trachomatis).
Control lower respiratory infections caused by infection with H. influenzae. Enteritis caused by salmonellae, shigellae, or campylobacters. - Adverse effects
Occurrence of tendinitis in adults resulting in tendon rupture, and phototoxicity. - Ends with “-floxacin”
quinolones and fluoroquinolones
- Clinical Uses
Active in vitro against some gram-positive and gram-negative cocci, some enteric bacteria, mycobacteria, chlamydiae, and poxviruses.
Some clinically useful agents include rifampin, rifabutin, rifaximin, and rifapentine. - Adverse effects
Rifampin imparts a harmless orange color to urine, sweat, and contact lenses.
rifamycins
- Clinical Uses
Active against gram-negative and gram-
positive bacteria, chlamydiae, nocardiae, and protozoa.
Prontosil red, silver sulfadiazine, The “soluble” sulfonamides (trisulfapyrimidines, sulfisoxazole), sulfamethoxypyridazine, sulfamethoxazole (SMZ) - Adverse effects
Erythema multiforme. Stevens-Johnson syndrome. Toxic epidermal necrolysis. Contraindicated in G6PD Deficiency, hemolysis, and jaundice.
sulfonamides
Clinical Uses
Clinically combined with sulfonamides to
treat urinary tract infections, shigellosis, and salmonellosis and infections with other gram-negative bacterial infections and in pneumocystis pneumonia.
* Adverse effects
Megaloblastic anemia
trimethoprim, pyrimethamine, trimetrexate
- Clinical Uses
Used in combination with other antimycobacterial agents (especially ethambutol or rifampin) to reduce the emergence of resistant tubercle bacilli. - Adverse effects
Patients receiving INH excrete pyridoxine in excessive amounts, which results in peripheral neuritis.
isoniazid (INH)
- Clinical Uses
- Used in combination with other antimycobacterial agents to reduce the emergence of resistant tubercle bacilli.
- Adverse effects
The most common side effects are visual disturbances (red-green visual disturbance): reduction in visual acuity, optic neuritis, and perhaps retinal damage.
ethambutol
- Clinical Uses
Used in combination with other antimycobacterial agents to reduce the emergence of resistant tubercle bacilli. - Adverse effects
The major adverse effects of pyrazinamide are hepatotoxicity (most hepatotoxic among anti-TB drugs), nausea, vomiting, hypersensitivity, and hyperuricemia.
pyrazinamide